Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02367482 : Tryptophan Metabolism in Human Brain Tumors
Phase
AgesMin: 22 Years Max: N/A
Eligibility
Inclusion Criteria:

1. Clinical and MRI diagnosis of recurrent GBM.

2. Age =22 years.

3. Patient agrees to NovoTTF treatment but has not started treatment yet.

4. Patient agrees to undergo a baseline and a follow-up AMT-PET scan during NovoTTF
treatment.

5. Patient able to provide informed consent.

Exclusion Criteria:

1. Resective surgery within 2 months prior to the initial AMT-PET scan (acute/subacute
post-surgical inflammatory changes may cause false positive increased uptake on
AMT-PET).

2. Severe increased intracranial pressure, status epilepticus, or other severe
complications of the tumor, requiring emergency or urgent intervention.

3. Positive pregnancy test (because of radiation involved in PET scanning).
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02367482      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740